Rimonabant-a simple solution
Rimonabant is the diet pill that made a huge impression in the obesity treatments. Rimonabant is the main ingredient of Acomplia,the best diet drug in the world right now. The researchers at Sanofi Aventis one of the most highly recognized pharmaceuticals developers in the world are “responsible” with the apperence of this amaizing drug,that helps people to lose weight and not suffering major side effects.

What you can expect from Rimonabant?
There is a simple answer to this question: WEIGHT LOSS. It’s fast, easy and simple. But do not think you must not put any effort if you have many pounds to take of. You must do exercises and keep some restrictions in what you eat and how you eat,if your target is really high.
Rimonabant is recommended to be used on people who have a BMI over 30 or a BMI over 27 with associated risk factors. You must never take it while on anti-depressive medication. Rimonabant should be cautiously in people with moderate renal impairment, epilepsy, people using potent inhibitors and rare hereditary disorders and galactose intolerance. In addition those over 75 should take care when using the Rimonabant. Those who should not take Rimonabant include those with uncontrolled psychological disorders, a cardiovascular event in the last six months and patients who are breastfeeding or pregnant.

Scientist declared that when you start taking rimonabant you will start feel it’s benefits. Don’t worry about side effects, they are normal and will pass when the body gets used with the changes of your metabolism.
You must consult your doctor or a weight loss specialist before you buy rimonabant in order to see if rimonabant is a proper drug for you and how much you will need to take rimonabant. Also tell your doctor about all the medicines you use, (prescription and nonprescription) especially if you take: high blood pressure medicine, MAO inhibitors (e.g., furazolidone, linezolid, phenelzine, selegiline, tranylcypromine), any other weight loss pills. Do not start or stop any medicine without doctor or pharmacist approval.

FDA approval of diet drug rimonabant (Acomplia ) failed. That did not happen — in fact, rimonabant may never make it to market in the U.S,
and the great diet hope for 2008 is Merck’s diet drug taranabant.

Everybody knows that there is a big rivality between Sanofi and Merk.
Despite all the efforts Sanofi Aventis failed to get Acomplia in the US market.
Specialists reported that Acomplia is to dangerous because of adverse reaction (patients suffered depression) and suicide risk.
Obese Americans eager to hear more about taranabant got a teaser Jan. 10th, but the generally encouraging report in the January issue of the journal Cell Metabolism was again based on results from a phase II trial and not the big phase III trial underway these past two years.
The news, in fact, was very similar to the report on phase II results that Merck presented at the annual scientific meeting of the Obesity Society back on Oct. 24th. In the journal article, researchers said study participants taking varying doses of taranabant lost 8 to 14 pounds over a 12-week period.
Merck researchers said between one-fifth and one-third of patients in the phase II trial of taranabant experienced psychiatric adverse effects, including depressed mood, irritability, anger, mood swings, tearfulness, anxiety, insomnia, and nervousness.
Presumably, there will be more and better information on side-effect issues when Merck reports on results of its phase III taranabant trial later this year. No date has yet been set for the first reports from this trial.
We hope that Taranabant will have better luck and obtain access in US.
Not that We take their side but We have concrete facts to belive that more and more obese people buy Generic form of Acomplia and the results are slower and the side effects of Rimonabant are not well known.

No adverse reaction were reported with people using rimonabant and the benefits are impressive.